1. Home
  2. RILY vs IPSC Comparison

RILY vs IPSC Comparison

Compare RILY & IPSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RILY
  • IPSC
  • Stock Information
  • Founded
  • RILY 1973
  • IPSC 2019
  • Country
  • RILY United States
  • IPSC United States
  • Employees
  • RILY N/A
  • IPSC N/A
  • Industry
  • RILY Investment Managers
  • IPSC Medicinal Chemicals and Botanical Products
  • Sector
  • RILY Finance
  • IPSC Health Care
  • Exchange
  • RILY Nasdaq
  • IPSC Nasdaq
  • Market Cap
  • RILY 185.4M
  • IPSC 149.1M
  • IPO Year
  • RILY 2007
  • IPSC 2021
  • Fundamental
  • Price
  • RILY $5.05
  • IPSC $1.21
  • Analyst Decision
  • RILY
  • IPSC Strong Buy
  • Analyst Count
  • RILY 0
  • IPSC 4
  • Target Price
  • RILY N/A
  • IPSC $13.00
  • AVG Volume (30 Days)
  • RILY 1.3M
  • IPSC 497.4K
  • Earning Date
  • RILY 12-03-2024
  • IPSC 11-05-2024
  • Dividend Yield
  • RILY 39.60%
  • IPSC N/A
  • EPS Growth
  • RILY N/A
  • IPSC N/A
  • EPS
  • RILY N/A
  • IPSC N/A
  • Revenue
  • RILY $1,221,832,000.00
  • IPSC $2,684,000.00
  • Revenue This Year
  • RILY N/A
  • IPSC $244.52
  • Revenue Next Year
  • RILY N/A
  • IPSC $27.73
  • P/E Ratio
  • RILY N/A
  • IPSC N/A
  • Revenue Growth
  • RILY 19.73
  • IPSC 7.88
  • 52 Week Low
  • RILY $4.07
  • IPSC $1.14
  • 52 Week High
  • RILY $40.09
  • IPSC $5.51
  • Technical
  • Relative Strength Index (RSI)
  • RILY 46.55
  • IPSC 38.14
  • Support Level
  • RILY $4.52
  • IPSC $1.20
  • Resistance Level
  • RILY $4.93
  • IPSC $1.29
  • Average True Range (ATR)
  • RILY 0.34
  • IPSC 0.12
  • MACD
  • RILY -0.01
  • IPSC -0.01
  • Stochastic Oscillator
  • RILY 44.92
  • IPSC 2.71

About RILY B. Riley Financial Inc.

B. Riley Financial Inc is a diversified financial services company. The company through its subsidiaries offers investment banking and financial services to corporate, institutional, and high-net-worth clients and also asset disposition, valuation and appraisal, and capital advisory services to retail, wholesale, institutional, lenders, capital providers, private equity investors, and professional services firms in United States, Canada, and Europe. It also provides internet access and subscription services. The reportable operating segments of the company include Capital Markets, Wealth Management, Financial Consulting, Auction and Liquidation, Communications segment, and Consumer products segment.

About IPSC Century Therapeutics Inc.

Century Therapeutics Inc is a biotechnology company specializes in leveraging adult stem cells to develop advanced cell therapy products targeting cancer, autoimmune, and inflammatory diseases. Their innovative approach involves a genetically engineered allogeneic cell therapy platform comprising induced pluripotent stem cells (iPSCs), CRISPR-mediated precision gene editing, proprietary chimeric antigen receptors (CARs), Allo-EvasionTM technology, and cutting-edge manufacturing capabilities. This comprehensive platform aims to overcome the limitations of first-generation cell therapies by optimizing cell product performance, preventing rejection by the host immune system, and minimizing development and supply risks.

Share on Social Networks: